Quality of life in treated and never-treated schizophrenic patients

Acta Psychiatrica Scandinavica

Volumn 103, Issue 2, 2001, Pages 131-142

  Green, Carla A ^a   Fenn, Darien S ^b   Moussaoui, Driss ^c   Kadri, Nadia ^c   Hoffman, William F ^b  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

Author keywords

Cross cultural comparison; Dyskinesias; Quality of life; Schizophrenia; Signs and symptoms; Therapeutics

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DYSKINESIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOROCCO; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SCHIZOPHRENIA; SYMPTOMATOLOGY; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; CATCHMENT AREA (HEALTH); EMPLOYMENT; FEMALE; HUMANS; INTERPERSONAL RELATIONS; LEISURE ACTIVITIES; MALE; MIDDLE AGED; MOROCCO; OREGON; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STRESS, PSYCHOLOGICAL; TREATMENT REFUSAL;

EID: 0035136541     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2001.00088.x     Document Type: Article

References (45)

1. Quality of life in schizophrenia: Insight and subjective response to neuroleptics
2. On stigma and its consequences: Evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse
3. The meaning and management of neuroleptic medication: A study of patients with a diagnosis of schizophrenia
4. Quality of life of schizophrenic patients on medications and implications for new drug trials
5. Measurement of therapeutic response in schizophrenia. A critical survey
6. The construct validity of subjective quality of life for the severely mentally ill
7. An analysis of social competence in schizophrenia
8. Drug-induced Parkinsonism
9. Long-term clinical and social outcome studies in schizophrenia in relation to the cognitive and emotional side effects of antipsychotic drugs
10. Adverse effects of antipsychotic drugs
11. Bereichsspezifsche subjecktiv Lebensqualität und krankheitsbedingte einschränkungen chronisch schizophrener patienten
12. Influence of housing conditions and state of partner on conditioning and extinction of taste aversion to lithium and chlorpromazine
13. Subjective response to neuroleptics and the quality of life: Implications for treatment outcome
14. Drugs and the quality of life: The patient's point of view
15. The effectiveness of stigma coping orientations: Can negative consequences of mental illness labeling be avoided?
16. Severe mental illness: Coping strategies and needs for home- and community-based care
17. Family burden and family stigma in major mental illness
18. Psychiatric illness and family stigma
19. Mental health services and research in the Arab world
20. The meaning of family ties
21. Quality of life of community mental health program clients: Validating a measure
22. Quality of life issues and assessment among persons with schizophrenia
23. The positive and negative syndrome scale (PANSS) for schizophrenia
24. The brief psychiatric rating scale
25. Psychiatric problems in a developing country Iraq
26. Overview: Arabic cultural psychiatry
27. Self-reported life satisfaction and treatment factors in patients with schizophrenia, major depression and anxiety disorder
28. A better outlook for schizophrenics living in extended families
29. Rehabilitation of schizophrenics by the extended family
30. Topics for our times: Can we learn from the care of persons with mental illness in developing countries?
31. Outcome in schizophrenia and related disorders compared between developing and developed countries. A recursive partitioning re-analysis of the WHO DOSMD data
32. Quality of life of community mental health program clients: Validating a measure
33. Subjective and external assessments of quality of life in schizophrenia: Relationship to insight